BRZE's second-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
Vous n'êtes pas connecté
In light of reputation damage from the global IT outage incident and slowing sales growth concerns, it is prudent to stay away from CrowdStrike (CRWD) for now.
BRZE's second-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
Despite CELH's strategic focus, slowing revenue growth, shrinking market share, dependence on a single distributor and high input costs raise...
Given TEAM's decelerating sales and customer growth, along with competitive pressure, it is wise to stay away from investing in the stock right now.
ORCL's progress in driving cloud adoption and delivering innovative AI solutions signals optimism for investment ahead of fiscal Q1 results.
ORCL's progress in driving cloud adoption and delivering innovative AI solutions signals optimism for investment ahead of fiscal Q1 results.
The combination of slowing growth, lowered guidance and bearish technical indicators suggests that CRWD stock could face downside pressure in the near...
Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock...
Infosys is gaining from the steady flow of clients and partnerships resulting in solid top-line growth potential.
Infosys is gaining from the steady flow of clients and partnerships resulting in solid top-line growth potential.
Despite SNPS stock's price drop, the company's AI-driven growth potential and strategic acquisitions make a compelling case for holding it for now.